Events and Presentations

Recent Presentations

Annual Meeting of the European Association for the Study of the Liver (EASL)

Title: Long term persistence of Anti-HBs antibodies after vaccination with a 3-antigen HBV vaccine compared to a single-antigen HBV vaccine
Date: June 26, 2022
Download: PDF

World Vaccine Congress Washington 2022

Title: VBI-2901: Multivalent Coronavirus Vaccine
Date: April 21, 2022
Download: PDF

World Vaccine Congress Washington 2022

Title: Safety & Immunogenicity of a New 3-Antigen Hepatitis B Vaccine, PreHevbrio™ [Hepatitis B Vaccine (Recombinant)]
Date: April 20, 2022
Download: PDF

Recent & Upcoming Events

Jefferies Healthcare Conference

Date: June 8, 2022
Time:1:30-1:55 PM ET
Webcast: Watch

32nd Annual Oppenheimer Healthcare Conference

Date: March 16, 2022
Time: 10:00-10:30 AM ET
Webcast: Replay

B. Riley Securities 2022 Oncology Investor Conference

Date: January 28, 2022
Webcast: Replay
Download Presentation: PDF

World Vaccine & Immunotherapy Congress 2021

Title: Development of eVLP Platform for Viral Associated Cancers
Date: December 1, 2021
Download Presentation: PDF

FDA Approval of PreHevbrio™ for the Prevention of Hepatitis B in Adults

Date: December 1, 2021
Webcast: Replay

Jefferies London Healthcare Conference

Date: November 17, 2021
Webcast: Replay

Guggenheim 2nd Annual Vaccines & Infectious Disease Conference

Date: October 5, 2021
Webcas: Replay

New Preclinical Data and Initiation of VBI-2905 Clinical Study Targeting Broadened Immunity Against COVID-19 and Variants of Concern

Date: September 29, 2021
Webcast: Replay
Download Presentation: PDF

VBI’s eVLP COVID-19 Vaccine Candidate: Initial Positive Phase 1 Data

Date: June 29, 2021
Webcast: Replay
Download Presentation: PDF

Canadian Liver Meeting 2021

Title: Higher seroproteciton rates (SPR) and higher anti-HBs concentrations in adults age 18+ achieved with 3-antigen hepatitis B vaccine (3A-HBV) compared to 1-antigen hepatitis B vaccine (1A-HBV): Results from the pivotal, double-blind, randomized Phase 3 study (PROTECT)
Date: May 4, 2021
Download Oral Presentation: PDF